Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

Hospital Geral de Fortaleza

Status and phase: Completed; Phase 4

Conditions: Contraception; Menopause; Quality of Life

Treatments: Drug: ethinylestradiol 15 mcg; Drug: gestoden 60 mcg

Study type: Interventional

Funder types: Other

Identifiers

NCT01174524

MedleyHGF

Details and patient eligibility

About

The purpose of this study is to determine whether low-dose contraceptive pills are effective in the improvement of quality of life in patients in the different phases of menacme.

Enrollment: 100 patients

Sex: Female

Ages: 15 to 46 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Fertile women with indication of use of contraceptive pills

Exclusion criteria

• Fertile women with any surgical contraceptive method
• Women in menopause
• Diseases the forbidden the use of the drug

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

gestoden and ethinylestradiol

Experimental group

Description:

Gestoden 60 mcg plus ethinylestradiol 15 mcg, once a day, administered in 24∕4 regimen, for three months. The use of gestoden and ethinylestradiol can do an improvement of the quality of life before and after the use of the drug.Numerous large clinical trials have shown that this combination is as effective in preventing pregnancies as other oral contraceptives presently on the market. Irregular bleeding and spotting rates appear to be at least as good as older formulations. In general, the incidence of side effects associated with the progestin and estrogen components tends to be low, with very little impact on lipid and carbohydrate metabolism. . For this, the regimen can ameliorate the quality of life of the patients.

Treatment:

Drug: gestoden 60 mcg

Drug: ethinylestradiol 15 mcg